Previous close | 456.10 |
Open | 455.99 |
Bid | 0.00 |
Ask | 0.00 |
Strike | 380.00 |
Expiry date | 2024-08-16 |
Day's range | 455.68 - 456.11 |
Contract range | N/A |
Volume | |
Open interest | 7 |
Nvidia’s fight to remain the world’s most valuable company begins, disappointing retail sales raise hopes for a September rate cut, and more news to start your day.
On Jun 10, the FDA's Peripheral and Central Nervous System Drugs Advisory Committee (PCNS) voted 11-0, unanimously recommending the approval of Eli Lilly's (LLY) Alzheimer's disease drug, donanemab.
Moody's released a new report Tuesday that reins in Wall Street expectations for the impact of GLP-1s on other industries.